Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT Completed Phase 1 / 2 Trials for KRN-7000 (DB12232)

IndicationStatusPhase
DBCOND0052845 (Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01379209Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)Treatment